folfiri
Showing 1 - 25 of 68
Metastatic Colorectal Cancer, CRC, KRAS/NRAS Mutation Trial (Onvansertib, FOLFIRI, Bevacizumab)
Not yet recruiting
- Metastatic Colorectal Cancer
- +2 more
- Onvansertib
- +3 more
- (no location specified)
Oct 24, 2023
Colorectal Cancer Trial in Hangzhou (Ametumumab, Anti-PD-1 mAb, Cetuximab)
Not yet recruiting
- Colorectal Cancer
- Ametumumab
- +3 more
-
Hangzhou, Zhejiang, ChinaSir Run Run Shaw Hospital, Zhejiang University School of Medicin
Jan 30, 2023
Metastatic Colorectal Cancer Trial in Shanghai (Fruquintinib, FOLFIRI, mFOLFOX6)
Not yet recruiting
- Metastatic Colorectal Cancer
- Fruquintinib
- +2 more
-
Shanghai, Shanghai, ChinaDepartment of Colorectal Surgery Fudan University Shanghai Caner
Nov 23, 2022
Metastatic Colorectal Cancer Trial in Hangzhou (FOLFIRI)
Recruiting
- Metastatic Colorectal Cancer
- FOLFIRI
-
Hangzhou, Zhejinag, ChinaSAHZU
Apr 30, 2022
Metastatic Colorectal Cancer, KRAS Gene Mutation Trial in United States (Onvansertib, Bevacizumab, FOLFIRI)
Active, not recruiting
- Metastatic Colorectal Cancer
- KRAS Gene Mutation
- Onvansertib
- +2 more
-
Phoenix, Arizona
- +6 more
Nov 10, 2022
Neuroendocrine Tumor Trial in Beijing (PM8002, FOLFIRI)
Recruiting
- Neuroendocrine Neoplasm
- PM8002
- FOLFIRI
-
Beijing, ChinaChinese PLA General Hospital
May 25, 2023
Colorectal Cancer, Metastatic Colorectal Cancer Trial in United States (Onvansertib, FOLFIRI, Bevacizumab)
Recruiting
- Colorectal Cancer
- Metastatic Colorectal Cancer
- Onvansertib
- +2 more
-
Birmingham, Alabama
- +38 more
Jan 25, 2023
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum Trial in Germany (Cetuximab, FOLFIRI)
Active, not recruiting
- Adenocarcinoma of the Colon
- Adenocarcinoma of the Rectum
- Cetuximab
- FOLFIRI
-
Bochum, Germany
- +3 more
Oct 14, 2021
Metastatic Colorectal Cancer, Solid Tumor Trial in Chonam, Gyeonggi-do, Seoul (irinotecan, FOLFIRI)
Completed
- Metastatic Colorectal Cancer
- Solid Tumor
- irinotecan
- FOLFIRI
-
Chŏnam, Korea, Republic of
- +5 more
Mar 1, 2022
Pancreatic Ductal Adenocarcinoma, Locally Advanced Cancer, Metastatic Cancer Trial in France (FOLFIRI, OSE2101)
Recruiting
- Pancreatic Ductal Adenocarcinoma
- +2 more
- FOLFIRI
- OSE2101
-
Amiens, France
- +27 more
Oct 19, 2021
Gastroesophageal Adenocarcinoma Trial in Orange (device, combination product, drug)
Not yet recruiting
- Gastroesophageal Adenocarcinoma
- ctDNA Blood Test
- +8 more
-
Orange, CaliforniaChao Family Comprehensive Cancer Center, University
Feb 8, 2023
Colorectal Carcinoma Trial (mFOLFOX6, FOLFIRI, pembrolizumab)
Pancreatic Cancer, Adenocarcinoma of the Pancreas, Squamous Cell Carcinoma of Pancreas Trial in Boston (ZIMBERELIMAB,
Recruiting
- Pancreatic Cancer
- +3 more
- ZIMBERELIMAB
- +3 more
-
Boston, MassachusettsDana Farber Cancer Institute
Jan 9, 2023
Neuroendocrine Carcinomas Trial in France (Folfiri-bevacizumab, Folfiri)
Recruiting
- Neuroendocrine Carcinomas
- Folfiri-bevacizumab
- Folfiri
-
Amiens, France
- +26 more
Jan 26, 2022
Metastatic Colorectal Cancer, KRAS Gene Mutation Trial (Onvansertib, Bevacizumab, FOLFIRI)
No longer available
- Metastatic Colorectal Cancer
- KRAS Gene Mutation
- Onvansertib
- +2 more
- (no location specified)
Jan 18, 2021
BRAF V600E, Metastatic Colorectal Cancer Trial in China (Encorafenib, Cetuximab, FOLFIRI)
Recruiting
- BRAF V600E
- Metastatic Colorectal Cancer
- Encorafenib
- +2 more
-
Beijing, Beijing, China
- +33 more
Dec 20, 2022
Gastrointestinal Cancer, Metastatic Trial in Worldwide (BI 905711, FOLFIRI, Bevacizumab)
Recruiting
- Gastrointestinal Cancer, Metastatic
- BI 905711
- +2 more
-
Houston, Texas
- +3 more
Aug 9, 2022
Colorectal Cancer Metastatic Trial in Ireland, United States (Regorafenib (BAY 73-4506), FOLFIRI, Placebo)
Completed
- Colorectal Cancer Metastatic
- Regorafenib (BAY 73-4506)
- +2 more
-
Denver, Colorado
- +23 more
Dec 10, 2020
Pancreatic Adenocarcinoma Trial in Providence (FOLFIRI, FOLFIRINOX, TriSalus Infusion System)
Withdrawn
- Pancreatic Adenocarcinoma
- FOLFIRI
- +2 more
-
Providence, Rhode IslandRoger Williams Medical Center
May 27, 2021
Non-Small Cell Lung Carcinoma (NSCLC), Colorectal Cancer (CRC), Other Solid Tumors Trial in Israel (Selinexor 100 mg, Docetaxel,
Recruiting
- Non-Small Cell Lung Carcinoma (NSCLC)
- +2 more
- Selinexor 100 mg
- +6 more
-
Ashdod, Israel
- +10 more
Jan 30, 2023
Advanced Solid Tumors Trial in United States (paclitaxel, FOLFIRI, ABT-165)
Active, not recruiting
- Advanced Solid Tumors
- paclitaxel
- +3 more
-
Scottsdale, Arizona
- +9 more
Mar 23, 2022
Unresectable Metastatic Colorectal Cancer Trial in Belgium, United States (CYAD-101, FOLFOX, FOLFIRI)
Recruiting
- Unresectable Metastatic Colorectal Cancer
- CYAD-101
- +2 more
-
Tampa, Florida
- +3 more
Nov 19, 2020